Status:
COMPLETED
Brief Behavioral Treatment for Insomnia in Cancer Survivors
Lead Sponsor:
State University of New York at Buffalo
Collaborating Sponsors:
Roswell Park Cancer Institute
National Institute of Nursing Research (NINR)
Conditions:
Chronic Insomnia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose is to determine whether brief behavioral treatment is effective for insomnia in cancer survivors.
Detailed Description
A randomized controlled clinical trial will be used to test the efficacy of this brief behavioral treatment compared to attention control on sleep, mood, functional, status and quality of life and det...
Eligibility Criteria
Inclusion
- \> or = 4 weeks from surgery for cancer treatment; chemotherapy and/or radiation therapy; no wait for hormone therapy or targeted treatment for stage I, II, or III: breast, colorectal, prostate, lung cancer
- chronic insomnia
Exclusion
- Other preexisting sleep disorders except those with OSA stable on CPAP
- Unstable medical illnesses
Key Trial Info
Start Date :
June 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT03810365
Start Date
June 6 2019
End Date
November 1 2023
Last Update
July 3 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University at Buffalo
Buffalo, New York, United States, 14214
2
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States, 14263